1 / 7

In-vitro Diagnostic Services Market Update, Analysis and Forecast Report, 2018 – 2024

In-vitro Diagnostic Services Market size is set to exceed USD 63 billion by 2024; according to a new research report by Global Market Insights.

Toshitbhat
Télécharger la présentation

In-vitro Diagnostic Services Market Update, Analysis and Forecast Report, 2018 – 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. In-vitro Diagnostic Services Market size to surpass $63 bn by 2024: Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. KeyInsights from In-vitro Diagnostic Services Market : • In-vitro Diagnostic Services Market size is set to exceed USD 63 billion by 2024; according to a new research report by Global Market Insights. • Growing prevalence of chronic diseases such as cancer should have positive impact on the demand for in-vitro diagnostic (IVD) services. According to WHO, in 2015, there were around 8.8 million deaths globally due to cancer that will augment demand for IVD services. Also, as reported by World Cancer Research Fund International, there were around 1.4 million cases of colorectal cancer globally that will assure inflated demand for diagnostic services in forthcoming years. However, excessive cost of the diagnostic services and software utilized will restrain the industry growth.

  3. Continued... • Testing services segment will grow at 5.7% over the forecast timeline and the high segmental growth will be attributed to the availability of superior quality in-vitro diagnostic services. Moreover, increasing mortality rates due to cancer and other viral infections should augment the business growth over forecast timeframe. • Laboratories segment held an enormous market share of 29.3% in 2017 and is anticipated to follow high growth trends in upcoming years. Increase in rate of detection of diabetes cases in South African and Asian countries will augment the segmental growth and escalate the demand for in-vitro diagnostic services. Additionally, growing incidence of chronic infections such as HIV and others will ensure high demand for laboratory diagnostic services. According to U.S. Statistics, around 1.1 million people in the U.S. were infected with AIDS that will positively influence business growth.

  4. U.S. In-vitro Diagnostic Services Market, By Software, 2013 – 2024 (USD Billion)

  5. Browse Full Market Research Report On In-vitro Diagnostic Services Market @ h https://bit.ly/2OuQmUa Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/2889

  6. 360° Analysis • Application Trends • Laboratories segment held an enormous market share of 29.3% in 2017 and is anticipated to follow high growth trends in upcoming years. Increase in rate of detection of diabetes cases in South African and Asian countries will augment the segmental growth and escalate the demand for in-vitro diagnostic services. Additionally, growing incidence of chronic infections such as HIV and others will ensure high demand for laboratory diagnostic services. According to U.S. Statistics, around 1.1 million people in the U.S. were infected with AIDS that will positively influence business growth. • Regional Trends • U.S. dominated North America in-vitro diagnostic services market and was valued at USD 16.7 billion in 2017 as a result of increasing demand for diagnostic services and growing adoption rate of software. • Competitive Market Share • Major industry players include BioRad, DexCom, Nova Biomedical, OraSure, Pearl Pathways, Phenomenex, Qiagen, Roche diagnostics, Siemens, Sysmex and Thermofisher.

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related